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A novel type IV collagen-degrading metalloproteinase was purified from the conditioned media of a murine metastatic sarcoma cell line. The mole- 
cular weight of the purified enzyme was determined to be 100 kDa by SDS-PAGE, while 700 kDa by gel filtration suggesting that the enzyme 
has a multimer structure. This enzyme degrades type IV collagen, but neither type I collagen nor casein. The failure of trypsin treatment to enhance 
the enzyme activity suggested that the purified enzyme did not require activation. Although the enzyme seems to be classified as a matrix metallopro- 
teinase, it was inhibited by neither tissue inhibitor of metalloproteinases (TIMP) nor TIMP-2 and thus represents anovel type IV collagen-degrading 
metalloproteinase. 
Type IV collagenase; Metastasis; TIMP (tissue inhibitor of metalloproteinase); Basement membrane; Metalloproteinase; Mouse T241 sarcoma cell 
1. INTRODUCTION 
One of the important steps of cancer metastasis i  the 
traversion of basement membranes by tumor cells. A 
neutral metalloproteinase, which degrades type IV col- 
lagen, a major structural component of basement mem- 
brane, has been identified in a number of cultured 
tumor cell lines [I ,2]. Gelatinaseitype IV collagenase, 
either 72 kDa [3] or 92 kDa [4] enzyme, and stromelysin 
[5-71 have been reported to degrade type IV collagen 
as one of their substrates. These enzymes are generally 
secreted as proenzyme and activated by organomer- 
curia1 compounds or some proteinases uch as trypsin 
and plasmin [8], and are inhibited by TIMP [9,10]. In 
the present study, we report the purification and 
characterization of a novel type IV collagen-degrading 
metalloproteinase from murine sarcoma cells. 
Shodex WS-803F and 804F column, Showa Denko K.K., Tokyo, 
Japan; L-[2,3,4,S-3H]proline and [‘4C]methylated a-casein, Amers- 
ham, Bucks, UK. All other chemicals used were reagent grade 
materials from various commercial sources. 
2.2. Preparation of substrates 
Engelbreth-Holmes-Schwarm (EHS) were maintained C57BL/6J 
mice. [‘H]Proline-labeled type IV collagen (300 dpm/,cg) was 
prepared from EHS mouse tumor according to Salo et al. [ll]. 
[‘4C]Glycine labeled type I collagen (20 dpm/Fg) was prepared from 
guinea-pig skin according to Terato et al. [12]. [i4C]Gelatin was 
prepared from [‘4C]type I collagen by heating at 60°C for 30 min. 
2.3. Enzyme assay 
2. MATERIALS AND METHODS 
Type I collagen, gelatin and casein degrading activities were all 
assayed according to Murphy et al. [13] using [i4C]type I collagen, 
[14C]gelatin (1000 dpm/200 al/tube) and [“CJcasein (2000 dpm/250 
@tube). Type IV collagen degrading activity was assayed according 
to Salo et al. [II] using [‘HItype IV collagen (1500 dpm/650$/tube) 
with or without trypsin treatment. The effects of inhibitors were 
assessed by addition in the assay. One unit (U) of collagenase was 
defined as the amount of enzyme which degrades 1 fig of substrate per 
min at 37°C. One unit (U) of collagenase inhibitor is defined as the 
amount of protein required for 50% inhibition of 2 U of collagenase. 
2. I. Materials 
Materials were obtained from the following sources: TSK DEAE- 
fPW column, Toyo Soda Manufacturing Co. Ltd, Tokyo, Japan; 
2.4. Purification of type IV collagen-degrading enzyme 
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Conditioned media from cultures of the highly metastatic murine 
T241 sarcoma cells grown under serum-free conditions was harvested 
according to Liotta et al. [14]. All the following procedures were per- 
formed at 4’C. The media proteins were precipitated with ammo- 
nium sulfate from saturation of 25-801, and the precipitate was 
dissolved in and dialyzed against buffer A (50 mM Tris-HCl, pH 7.5). 
The crude enzyme preparation (100 ml) was concentrated to 10 ml by 
ultrafiltration using an Amicon PM-10 membrane. The sample was 
applied to a DEAE-SPW (HPLC) column (2 x 12 cm) equilibrated 
with buffer A. The column was eluted with a O-O.5 M NaCl gradient. 
The majority of the enzyme activity was eluted with 0.25 M NaCl. 
Also, several minor peaks of type IV collagen-degrading activity was 
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Table I 
Purification of a new type IV collagen-degrading metalloproteinase from mouse metastatic sarcoma cells 
Purification steps Total Total Specific Purification 
protein activity activity (fold) 
(mg) (mu) (mU/mg protein) 
Conditioned medium 
(NH&S04 ppt. 
DEAE-SPW (HPLC) 
Gel filtration (Shodex 
WS-803F, HPLC) 
1120 32 300 29 1.0 
378 15 600 41 1.4 
6.1 9770 1590 55 
0.11 220 2000 69 
detected. These minor peaks may correspond to 72 kDa or 92 kDa 
gelatinase/type IV collagenases and stromelysin. The main peak of 
activity was concentrated to 1 ml, followed by gel-filtration (Shodex 
WS-803F, HPLC). The active fractions were collected and pooled. 
2.5. Partial purification of HT1080 gelatinme/type IV collagenase 
Serum-free culture medium of HT1080 cells was passed through a 
DEAE-5PW (HPLC) column equilibrated with buffer A and washed 
with same buffer containing 0.20 M NaCl, followed by elution with 
0.25 M NaCl. The enzyme preparation was activated by APMA. The 
gelatin zymographic analysis suggested this enzyme corresponded to 
the 72 kDa gelatinase/type IV collagenase. 
2.6. Purification of TIMP and TIMP-2 
TIMPs were purified as reported previously from bovine aortic 
medial tissue [IS], bovine dental pulp [16], human amniotic fluid 
[17], human gingival fibroblast [18]. 
TIMP-2 was purified more than 2000-fold from the culture 
medium of mouse colon 26 carcinoma cells using DF-52 Cellulose, 
CM-52 Cellulose, Ultrogel AcA 54, Con A-Sepharose and Sephadex 
G-50 Superfine columns (Kishi, J., Ogawa, K., Yamamoto, S. and 
Hayakawa, T., submitted). 
3. RESULTS AND DISCUSSION 
A new type IV collagen-degrading enzyme was 
purified from the culture media of mouse T241 sar- 
coma cells by ammonium sulfate precipitation, anion 
exchange (HPLC) and gel filtration (HPLC) column 
-94k 
-67k 
-43k 
39k- 
-3Ok 
chromatographies (Table I). The molecular mass of the 
new enzyme was determined to be 100 kDa by SDS- 
PAGE in either reducing (Fig. 1A) or nonreducing con- 
ditions (data not shown), while it was estimated to be 
700 kDa by gel filtration (Fig. 1B). These results sug- 
gest that the new enzyme has a multimer structure, and 
disulfide covalent bonds are not required for multime- 
rization. 
The purified enzyme did not degrade type I collagen 
and casein at all. Gelatin was a poor substrate com- 
pared to type IV collagen (data not shown). Further- 
more, this enzyme did not require activation. Treat- 
ment of the enzyme with trypsin (5 pug/ml) at 37°C for 
various incubation times did not increase enzyme ac- 
tivity (data not shown). 
Recently a high-molecular-mass type IV collagen- 
specific metalloproteinase having a molecular mass of 
1000 kDa was purified from human carcinoma tissue 
[ 191. The 1000 kDa enzyme was essentially inactive and 
activated by trypsin. The enzyme we described here 
seems to resemble the 1000 kDa enzyme in respect to 
molecular mass and substrate specificity. Both en- 
zymes, however, are quite different in respect to their 
latency, since the 1000 kDa enzyme is latent and re- 
quires activation. 
Fig. 1. Molecular mass of the T241 sarcoma type IV collagen-degrading metalloproteinase. (A) 7.5% SDS-PAGE in the presence of P- 
mercaptoethanol. Gels were stained with Coomassie brilliant blue. (Lanes 1 and 3) molecular mass standards; (lane 2) purified type IV collagen- 
degrading enzyme. (B) Elution profile of the purified enzyme on Showdex WS-804F gel filtration (HPLC), detected by aosorbance at 280 nm. 
Column was equilibrated with 50 mM Tris-HCl/O.Z M NaCl (pH 7.5) and the flow rata was 0.5 ml/min. Fractions were collected and subjected 
to the analysis of type IV collagen-degrading activity. Enzyme activity peak coincided with the elution peak of protein. Molecular mass standards 
used were thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa). 
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Table II 
Inhibitory effects of TIMP and TIMP-2 on a new type IV collagen-degrading metalloproteinase and 
HT1080 gelatinase/type IV collagenase 
Inhibitors 
(sources) 
Inhibitor/enzyme ratio 
(U/U) 
Inhibition (%) 
A new type IV HT1080 gelatinase/ 
collagen-degrading type IV collagenase 
enzyme 
TIMP (human gingival 
fibroblast) 
1 ND 30.9 
10 ND 91.3 
50 0 ND 
250 27.8 ND 
TIMP-2 (mouse colon 26 1 ND 0 
cells) 10 ND 80.3 
50 0 ND 
250 19.0 ND 
The purified new enzyme was inhibited about 80% 
ND = not determined. 
by 7.5 mM EDTA, but was insensitive to the thiol pro- 
tease inhibitor N-ethylmaleimide, and the serine pro- 
tease inhibitor, aprotinin (data not shown), indicating 
that the new enzyme is a metalloproteinase. It has been 
shown that most of type IV collagen-degrading en- 
zymes such as gelatinase/type IV collagenase, either 72 
kDa or 92 kDa enzyme, and stromelysin are metallo- 
proteinases and are inhibited by TIMP [20]. The high- 
molecular-mass type IV collagen-specific metallopro- 
teinase is also inhibited by TIMP [21]. The new en- 
zyme, however, was not inhibited by any TIMP derived 
from bovine aortic cells, bovine dental pulps, human 
gingival fibroblasts and human amniotic fluid which 
are all known to be potent inhibitors of interstitial 
collagenase [15-181. All of these TIMPs were con- 
firmed to inhibit gelatinaseitype IV collagenase from 
human HT1080 fibrosarcoma cells in this study. In- 
hibitory effects of one of the TIMPs, derived from 
human gingival fibroblasts, are summarized in 
Table II. 
Recently a new TIMP, called TIMP-2, has been 
reported from several laboratories [22-241. TIMP-2 
shows about 41% similarity to the TIMP and inhibits 
interstitial collagenase and gelatinase/type IV col- 
lagenase at almost the same concentrations. Having 
recently purified TIMP-2 from the culture media of 
mouse colon 26 cells (Kishi, J., Ogawa, K., Yamamoto, 
S. and Hayakawa, T., submitted), we checked whether 
it inhibits the new enzyme and HT1080 gelatinase/type 
IV collagenase. As shown in Table II, the new enzyme 
resisted inhibition by TIMP-2, while the HT1080 type 
IV degrading activity was completely inhibited. 
Mikuni-Takagaki and Cheng found neutral metallo- 
proteinases which degraded proteoglycan and/or 
gelatin in developing chick endochondral bone [27]. 
These enzymes are distinct from our enzyme in respect 
to the substrate specificity; however, it is interesting 
that these enzymes are also insensitive to TIMP and 
probably to TIMP-2. 
In conclusion, neither TIMP nor TIMP-2 inhibited 
the new enzyme. As TIMP is known to be widely 
distributed in tissues and body fluids [25-261, the new 
TIMP-insensitive enzyme may play an important role 
in tumor invasion and metastasis. 
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